{
    "2020-07-09": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Health Giant Johnson & Johnson On Deck To Report â€” Here's What We Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "report",
                        "health giant"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Analysts Estimate Abbott (ABT) to Report a Decline in Earnings: What to Look Out for",
                "features": {
                    "keywords": [
                        "Abbott",
                        "decline",
                        "earnings"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "outperforming",
                        "medical stocks"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes",
                "features": {
                    "keywords": [
                        "Bio-Rad",
                        "Coronavirus PCR Tests",
                        "cost woes"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}